Oncolytics Biotech Inc.
ONCY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $101 | $118 | $128 | $94 |
| - Cash | $16 | $35 | $12 | $41 |
| + Debt | $1 | $0 | $0 | $1 |
| Enterprise Value | $86 | $84 | $117 | $53 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$35 | -$20 | -$19 | -$21 |
| % Margin | – | – | – | – |
| Net Income | -$32 | -$21 | -$19 | -$21 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.41 | -0.41 | -0.43 | -0.49 |
| % Growth | 0% | 4.7% | 12.2% | – |
| Operating Cash Flow | -$27 | -$28 | -$23 | -$22 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$27 | -$28 | -$23 | -$23 |